CENTRE OSCAR LAMBRET
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 251
- Market Cap
- -
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
Not Applicable
Not yet recruiting
- Conditions
- Cancer of the OvaryCancer of the Fallopian TubePeritoneal Cancer
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 371
- Registration Number
- NCT06969833
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
Recruiting
- Conditions
- Smoking CessationNicotine AddictionNicotine DependenceSmokingHead and Neck Neoplasms
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 100
- Registration Number
- NCT06910566
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients
Not Applicable
Not yet recruiting
- Conditions
- Vaginal DrynessBreast CancerVulvovaginal Atrophy
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 75
- Registration Number
- NCT06900374
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
Phase 2
Not yet recruiting
- Conditions
- Post-Mastectomy Neuropathic Pain Syndrome
- Interventions
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 123
- Registration Number
- NCT06807164
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, Hauts-de-France, France
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Tubo-ovarian CarcinomaHigh-grade Serous CarcinomaPrimary Peritoneal Carcinoma Stage IIIPrimary Peritoneal Carcinoma Stage IVPrimary Peritoneal Carcinoma
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 1100
- Registration Number
- NCT06726330
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions (HPV2-2303)
Phase 2
Recruiting
- Conditions
- Cervical Lesion
- Interventions
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 85
- Registration Number
- NCT06658405
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Superiority Trial Evaluating Digitalized Information Media for Patients with Advanced Sarcomas Receiving Second Line Treatment.
Not Applicable
Recruiting
- Conditions
- Locally Advanced Soft Tissue SarcomaSarcoma Metastatic
- Interventions
- Other: Dematerialized Personalized Care Plan (ePCP)
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 377
- Registration Number
- NCT06211257
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, Auvergne-Rhône-Alpes, France
🇫🇷CHU Jean Minjoz, Besançon, Bourgogne-Franche-Comté, France
🇫🇷Centre Eugène Marquis, Rennes, Bretagne, France
Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
Terminated
- Conditions
- Cancer of Rectum
- Interventions
- Procedure: Stool collection
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 2
- Registration Number
- NCT06181201
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2
Recruiting
- Conditions
- Adenocarcinoma, Clear CellSex Cord-Stromal TumorCarcinoma, Small CellOvarian Germ Cell TumorMucinous Adenocarcinoma of OvaryCarcinosarcoma, OvarianSerous Tumor of OvaryStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal TumorsBorderline Ovarian Tumor
- Interventions
- Other: Oncological Follow-up
- First Posted Date
- 2022-08-15
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 88
- Registration Number
- NCT05500391
- Locations
- 🇫🇷
Centre François Baclesse, Caen, France
🇫🇷CHU Amiens, Amiens, France
🇫🇷Centre Oscar Lambret, Lille, France
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Phase 1
Recruiting
- Conditions
- Wilms Tumor
- Interventions
- First Posted Date
- 2022-05-20
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 28
- Registration Number
- NCT05384821
- Locations
- 🇫🇷
CHU Amiens Picardie, Amiens, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷CHU de Besancon, Besançon, France
© Copyright 2025. All Rights Reserved by MedPath